Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2024 06:00 ET | Source: Coppernico Metals Inc.

Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits at Sombrero

VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Coppernico Metals Inc. (TSX: COPR) (“Coppernico” or the “Company”), is pleased to provide an update on its inaugural drilling program...
February 05, 2024 06:00 ET | Source: Research Nester

Blood Group Typing Market revenue to hit USD 2 Billion by 2033, says Research Nester

New York , Feb. 05, 2024 (GLOBE NEWSWIRE) -- The global blood group typing market size is slated to expand at 7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 2 billion...
February 16, 2023 16:05 ET | Source: Predicine

Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays

HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, is committed to advancing genitourinary (GU) cancer detection and treatment decisions through its...
February 01, 2023 07:00 ET | Source: Apollo Silver Corp.

Apollo Reports Final Silver Intercepts from the Calico 2022 Drill Program

VANCOUVER, British Columbia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to report further assay results...
November 10, 2022 21:00 ET | Source: Predicine

Predicine to Introduce PredicineCOMPLETE™, its Genome-Wide Liquid Biopsy Solution, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

SILICON VALLEY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announces the introduction of PredicineCOMPLETE™, the organization’s most comprehensive...
September 20, 2022 09:00 ET | Source: Predicine

Predicine’s Liquid Biopsy Next-Generation Sequencing (NGS) Assay is Granted Breakthrough Device Designation by U.S. Food and Drug Administration

HAYWARD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company committed to advancing precision medicine in oncology and infectious diseases, announced...
August 09, 2022 08:00 ET | Source: Predicine

Predicine Expands to Europe with the recently launched CE-Marked cfDNA Assay PredicineCARE™ for Genomic Profiling in Blood and Urine

SILICON VALLEY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company, has launched its CE-marked PredicineCARE™ for genomic profiling in blood and urine....
June 01, 2021 06:30 ET | Source: Gold Bull Resources Corp.

Gold Bull encounters coarse gold in samples at Sandman, improved laboratory assay analysis underway – higher grades expected

VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report re-assay results of RC drill samples from...
March 22, 2021 08:00 ET | Source: Gold Bull Resources Corp.

REPEAT -- Gold Bull intersects 144.8m at 1.67g/t gold, including 6.1m at 10.75g/t gold in maiden drill hole at Sandman

VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report assay results for the first hole drilled...
March 22, 2021 02:00 ET | Source: Gold Bull Resources Corp.

Gold Bull intersects 144.8m at 1.67g/t gold, including 6.1m at 10.75g/t gold in maiden drill hole at Sandman

VANCOUVER, British Columbia, March 21, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report assay results for the first hole drilled...

Next Page keyboard_arrow_right